您现在的位置: 首页   -  产品中心   -  免疫学   -   抗体
KRAS (mutated GQ60GK) + (mutated Q61K) Recombinant Rabbit mAb (S-604-4)

KRAS (mutated GQ60GK) + (mutated Q61K) Recombinant Rabbit mAb (S-604-4)

货号: S0B0663
价格: 600
规格: 25μl
介绍: -
其他: -
产品规格
  • 宿主来源

    Rabbit
  • 抗原名称

    KRAS
  • 分子别名

    GTPase KRas, K-Ras 2, Ki-Ras, c-K-ras, c-Ki-ras, KRAS2, RASK2
  • 免疫原

    Synthetic Peptide
  • 细胞定位

    Cytoplasm
  • Accession

    P01116
  • 克隆号

    S-604-4
  • 抗体类型

    Recombinant mAb
  • 抗体同种型

    IgG
  • 应用

    IHC-P, ICC, WB
  • 纯化方式

    Protein A
  • 浓度

    0.5 mg/ml
  • 标记

    Unconjugated
  • 性状

    Liquid
  • 缓冲体系

    PBS, 40% Glycerol, 0.05% BSA, 0.03% Proclin 300
  • 储存条件

    12 months from date of receipt / reconstitution, -20 °C as supplied

稀释度
应用 稀释度
WB 1:1000
IHC-P 1:500
ICC 1:500
背景介绍
  • KRAS protein is a GTPase and plays a crucial role in downstream signaling pathways. The activity of KRAS protein is regulated by the ratio of GTP to GDP bound to it. When GTP is bound to KRAS protein, it activates downstream signaling pathways, promoting cell proliferation and survival. However, mutations in the KRAS gene, such as GQ60GK, can lead to the activation of KRAS protein, resulting in the constant activation of downstream signaling pathways and promoting cancer cell proliferation and metastasis. when KRAS undergoes the Q61K mutation, it becomes constitutively activated, even in the absence of activation by EGFR or other kinases, leading to continuous cell proliferation and ultimately cancer development. The KRAS (mutated Q61K) mutation is found in various types of tumors, most notably lung cancer and pancreatic cancer. In clinical treatment, the presence of this mutation may require the adoption of specific therapeutic strategies, as some targeted drugs designed for non-mutated KRAS may be ineffective against this mutant form.

  • 免疫印迹

    • WB result of KRAS (mutated GQ60GK) + (mutated Q61K) Rabbit mAb
      Primary antibody: KRAS (mutated GQ60GK) + (mutated Q61K) Rabbit mAb at 1/1000 dilution
      Lane 1: 293T whole cell lysate 20 µg
      Lane 2: 293T transfected with empty vector whole cell Lysate 20 µg
      Lane 3: 293T transfected with KRAS WT whole cell Lysate 20 µg
      Lane 4: 293T transfected with KRAS(Q61K) whole cell Lysate 20 µg
      Lane 5: 293T transfected with KRAS(GQ60GK) whole cell Lysate 20 µg
      Secondary antibody: Goat Anti-rabbit IgG, (H+L), HRP conjugated at 1/10000 dilution
      Predicted MW: 21 kDa
      Observed MW: 21 kDa

  • 免疫组化

    • IHC shows positive staining in paraffin-embedded 293T transfected with KRAS (Q61K) cells. Anti-KRAS (mutated GQ60GK) + (mutated Q61K) antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • IHC shows positive staining in paraffin-embedded 293T transfected with KRAS (GQ60GK) cells. Anti-KRAS (mutated GQ60GK) + (mutated Q61K) antibody was used at 1/500 dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

    • Negative control: IHC shows negative staining in paraffin-embedded 293T transfected with KRAS WT cells. Anti- KRAS (mutated GQ60GK) + (mutated Q61K) antibody was used at 1/××× dilution, followed by a HRP Polymer for Mouse & Rabbit IgG (ready to use). Counterstained with hematoxylin. Heat mediated antigen retrieval with Tris/EDTA buffer pH9.0 was performed before commencing with IHC staining protocol.

  • 免疫细胞化学

    • ICC shows positive staining in KRAS (GQ60GK) transfected HeLa cells. Anti- KRAS (mutated GQ60GK) + (mutated Q61K) antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

    • ICC shows positive staining in KRAS (Q61K) transfected HeLa cells. Anti- KRAS (mutated GQ60GK) + (mutated Q61K) antibody was used at 1/500 dilution (Green) and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

    • Negative control: ICC shows negative staining in KRAS wild-type transfected HeLa cells. Anti- KRAS (mutated GQ60GK) + (mutated Q61K) antibody was used at 1/500 dilution and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).

    • Negative control: ICC shows negative staining in vector transfected HeLa cells. Anti- KRAS (mutated GQ60GK) + (mutated Q61K) antibody was used at 1/500 dilution and incubated overnight at 4°C. Goat polyclonal Antibody to Rabbit IgG - H&L (Alexa Fluor® 488) was used as secondary antibody at 1/1000 dilution. The cells were fixed with 100% ice-cold methanol and permeabilized with 0.1% PBS-Triton X-100. Nuclei were counterstained with DAPI (Blue). Counterstain with tubulin (Red).